Close Menu

More articles about Research & Discovery

The partners are developing a new lab that will focus on research into protein biomarkers with medical, agricultural, and environmental applications.

A group led by Mount Sinai researchers said this methyltransferase, which is involved in sporulation, could be targeted to fight infections.

A regional court said certain 10x Genomics' products, including older GEM chips and some Chromium instruments, infringed a "utility model," similar to a patent.

Under the terms of the five-year grant, Coriell will continue to support the NINDS Human Genetics Research Center.

The firm, a spin-out of Barts Cancer Institute, is developing a mass spec-based test for identifying AML patients likely to respond to the drug midostaurin.

The firm will use the net proceeds to repurchase up to about $50 million of its senior convertible note due 2034, as well as for general corporate purposes.

Researchers found that about 12 percent to 15 percent of breast cancer patients carry multiple mutations in the gene, 95 percent of which are double mutations.

The company released data showing that its panel detects early-stage liver cancer with 71 percent sensitivity compared to 25 percent for the standard test.

AlloSure 3.0 can diagnose the very early stages of T-cell mediated rejection, allowing clinicians to begin anti-rejection therapies and monitor treatment.

The Diagenode services will utilize Bio-Rad's ddSEQ Single-Cell Isolator to encapsulate thousands of cell nuclei or whole cells into nanoliter-sized droplets.

The pilot seeks to enroll 100 All of Us participants who are pregnant into the ongoing NICHD's PregSource initiative, which collects patient-reported data.

Mitochondrial sequences suggest some haplogroups found in Finland today arrived in the region pre-Iron Age, though population distributions have shifted.

By uncovering mismatches between Y chromosomes and genealogies, researchers estimated historical rates of extra-pair paternity in Western Europe.

The trial aims to combine personal information, pharmacogenomics data, and machine-learning tools to select the best anti-seizure medication for patients. 

 

 

Genotypes for more than 12,000 individuals from the Americas revealed contributions from European colonization, the Atlantic slave trade, and other migrations.

This report contains a quantitative, evidence-based scoring framework to help guide the evaluation of constitutional CNVs across clinical labs.

A single-cell transcriptome study found increased numbers of cytotoxic CD4 T cells, which could be an adaptation to the later stages of aging.

The government-backed project aims to better understand genetic diversity around the South Asian country while helping to inform clinical applications.

The Chromium Connect, designed for pharma workflows and other high-volume customers, is one of several products coming out of 10x's R&D pipeline.

The system uses chemical epigenetic modifiers to activate the expression of target genes by recruiting an endogenous chromatin-activating machinery.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.